Statistics
Publications
17
Citations
1.3K
H-Index
13
Active since
2008
LingZhi Ma is an author at Moderna Therapeutics (United States) specializing in medicine, immunology, and vaccination.
Publications per year
2008–2024
17
17
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness
Kizzmekia S. Corbett, Darin K. Edwards, Sarah R. Leist et al. · 2020 · 142 citations · Full text
Preliminary Analysis of Safety and Immunogenicity of a SARS-CoV-2 Variant Vaccine Booster
Angela Choi, Matthew Koch, LingZhi Ma et al. · 2021 · 90 citations · Full text
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice
Angela Choi, Matthew Koch, Sayda M. Elbashir et al. · Vaccine · 2021 · 89 citations · Full text
1–5 of 17